Electromed Inc (ELMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Electromed Inc (ELMD) has a cash flow conversion efficiency ratio of 0.067x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.03 Million) by net assets ($45.44 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Electromed Inc - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Electromed Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ELMD total liabilities for a breakdown of total debt and financial obligations.
Electromed Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Electromed Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Industrial Saltillo S.A.B. de C.V
MX:GISSAA
|
0.008x |
|
Metall Zug AG
SW:METN
|
-0.001x |
|
IBKS No. 15 Special Purpose Acquisition Co. Ltd.
KQ:373200
|
-0.554x |
|
Europen Endustri Insaat Sanayi ve Ticaret A.S.
IS:EUREN
|
0.005x |
|
Even Construtora e Incorporadora S.A
SA:EVEN3
|
-0.038x |
|
Metal Powder Works Ltd
AU:MPW
|
-0.309x |
|
GE Power India Limited
NSE:GEPIL
|
1.009x |
|
Medical Facilities Corporation
TO:DR
|
0.118x |
Annual Cash Flow Conversion Efficiency for Electromed Inc (2008–2025)
The table below shows the annual cash flow conversion efficiency of Electromed Inc from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see ELMD market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $43.21 Million | $11.39 Million | 0.264x | +29.54% |
| 2024-06-30 | $44.55 Million | $9.07 Million | 0.204x | +483.04% |
| 2023-06-30 | $37.67 Million | $1.31 Million | 0.035x | +273.91% |
| 2022-06-30 | $34.17 Million | $-686.00K | -0.020x | -121.15% |
| 2021-06-30 | $32.42 Million | $3.08 Million | 0.095x | -31.57% |
| 2020-06-30 | $30.25 Million | $4.20 Million | 0.139x | +37.83% |
| 2019-06-30 | $25.73 Million | $2.59 Million | 0.101x | -9.77% |
| 2018-06-30 | $21.90 Million | $2.44 Million | 0.112x | +78.56% |
| 2017-06-30 | $19.07 Million | $1.19 Million | 0.062x | -52.84% |
| 2016-06-30 | $16.36 Million | $2.17 Million | 0.132x | -33.69% |
| 2015-06-30 | $13.92 Million | $2.78 Million | 0.200x | +23.19% |
| 2014-06-30 | $12.72 Million | $2.06 Million | 0.162x | +20.34% |
| 2013-06-30 | $13.93 Million | $1.88 Million | 0.135x | +273.42% |
| 2012-06-30 | $15.08 Million | $-1.17 Million | -0.078x | +19.25% |
| 2011-06-30 | $14.71 Million | $-1.42 Million | -0.096x | -218.12% |
| 2010-06-30 | $7.46 Million | $607.94K | 0.081x | +142.63% |
| 2009-06-30 | $6.06 Million | $-1.16 Million | -0.191x | -417.55% |
| 2008-06-30 | $4.04 Million | $243.16K | 0.060x | -- |
About Electromed Inc
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as we… Read more